Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Nonpharmacologic approaches to substance abuse treatment.

Carroll KM, Schottenfeld R.

Med Clin North Am. 1997 Jul;81(4):927-44. Review.

PMID:
9222261
2.

Screening and brief intervention for alcohol and other abuse.

Harris SK, Louis-Jacques J, Knight JR.

Adolesc Med State Art Rev. 2014 Apr;25(1):126-56. Review.

PMID:
25022191
3.

Treatment of nicotine dependence.

Haxby DG.

Am J Health Syst Pharm. 1995 Feb 1;52(3):265-81; quiz 314-5. Review.

PMID:
7749954
4.

Nicotine replacement therapy.

Thompson GH, Hunter DA.

Ann Pharmacother. 1998 Oct;32(10):1067-75. Review.

PMID:
9793600
5.

Outcome predictors in substance use disorders.

Ciraulo DA, Piechniczek-Buczek J, Iscan EN.

Psychiatr Clin North Am. 2003 Jun;26(2):381-409. Review.

PMID:
12778840
6.

State of the art treatments for cannabis dependence.

Danovitch I, Gorelick DA.

Psychiatr Clin North Am. 2012 Jun;35(2):309-26. doi: 10.1016/j.psc.2012.03.003. Epub 2012 Apr 10. Review.

7.

[Smoking reduction and temporary abstinence: new approaches for smoking cessation].

Le Houezec J, Säwe U.

J Mal Vasc. 2003 Dec;28(5):293-300. Review. French.

PMID:
14978435
8.

Intolerance for withdrawal discomfort and motivation predict voucher-based smoking treatment outcomes for smokers with substance use disorders.

Rohsenow DJ, Tidey JW, Kahler CW, Martin RA, Colby SM, Sirota AD.

Addict Behav. 2015 Apr;43:18-24. doi: 10.1016/j.addbeh.2014.12.003. Epub 2014 Dec 10.

9.

Understanding the neurobiology, assessment, and treatment of substances of abuse and dependence: a guide for the critical care nurse.

Genung V.

Crit Care Nurs Clin North Am. 2012 Mar;24(1):117-30. doi: 10.1016/j.ccell.2012.01.007. Review.

PMID:
22405717
10.

Smoking cessation treatment in community-based substance abuse rehabilitation programs.

Reid MS, Fallon B, Sonne S, Flammino F, Nunes EV, Jiang H, Kourniotis E, Lima J, Brady R, Burgess C, Arfken C, Pihlgren E, Giordano L, Starosta A, Robinson J, Rotrosen J.

J Subst Abuse Treat. 2008 Jul;35(1):68-77. Epub 2007 Oct 24.

PMID:
17951021
11.

Recent advances in the psychotherapy of addictive disorders.

Carroll KM.

Curr Psychiatry Rep. 2005 Oct;7(5):329-36. Review.

PMID:
16216150
12.
13.

Dependence potential and abuse liability of nicotine replacement therapies.

Hughes JR.

Biomed Pharmacother. 1989;43(1):11-7. Review.

PMID:
2659095
14.
15.

Substance abuse treatment for people with schizophrenia.

Bellack AS, Gearon JS.

Addict Behav. 1998 Nov-Dec;23(6):749-66. Review.

PMID:
9801714
16.

Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.

Rohsenow DJ, Tidey JW, Martin RA, Colby SM, Swift RM, Leggio L, Monti PM.

Addiction. 2017 Oct;112(10):1808-1820. doi: 10.1111/add.13861. Epub 2017 Jul 4.

PMID:
28498504
17.

[Management of alcohol use disorders in ambulatory care: Which follow-up and for how long?].

Benyamina A, Reynaud M.

Encephale. 2016 Feb;42(1):67-73. doi: 10.1016/j.encep.2015.12.010. Epub 2016 Jan 13. Review. French.

PMID:
26796554
18.

The coupling of nicotine and stimulant craving during treatment for stimulant dependence.

Magee JC, Winhusen T.

J Consult Clin Psychol. 2016 Mar;84(3):230-7. doi: 10.1037/ccp0000054. Epub 2015 Oct 12.

19.

Nicotine replacement therapy for smoking cessation.

Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD000146. doi: 10.1002/14651858.CD000146.pub4. Review.

PMID:
23152200

Supplemental Content

Support Center